Asymptomatic Primary Hyperparathyroidism

Albright, 1934, Hyperparathyroidism: a common and polymorphic condition as illustrated by seventeen proved cases from one clinic, JAMA, 102, 1276, 10.1001/jama.1934.02750160010003 Heath, 1980, Primary hyperparathyroidism: incidence, morbidity, and economic impact in a community, N Engl J Med, 302, 189, 10.1056/NEJM198001243020402 Silverberg, 2006, The diagnosis and management of asymptomatic primary hyperparathyroidism, Nat Clin Pract Endocrinol Metab, 2, 494, 10.1038/ncpendmet0265 Eastell, 2009, Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the Third International Workshop, J Clin Endocrinol Metab, 94, 340, 10.1210/jc.2008-1758 Bilezikian, 2008, Hypercalcemic states: differential diagnosis and acute management Fuleihan, 2002, Familial benign hypocalciuric hypercalcemia, J Bone Miner Res, 17, N51 Endres, 1991, Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: performance in the differential diagnosis of hypercalcemia and hypoparathyroidism, Clin Chem, 37, 162, 10.1093/clinchem/37.2.162 Nussbaum, 1987, Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia, Clin Chem, 33, 1364, 10.1093/clinchem/33.8.1364 Silverberg, 2003, Clinical utility of an immunoradiometric assay for whole PTH (1-84) in primary hyperparathyroidism, J Clin Endocrinol Metab, 88, 4725, 10.1210/jc.2002-021266 Silverberg, 2009, Presentation of asymptomatic primary hyperparathyroidism: proceedings of the Third International Workshop, J Clin Endocrinol Metab, 94, 351, 10.1210/jc.2008-1760 Bilezikian, 2004, Clinical practice: asymptomatic primary hyperparathyroidism, N Engl J Med, 350, 1746, 10.1056/NEJMcp032200 Silverberg, 1999, The effects of vitamin D insufficiency in patients with primary hyperparathyroidism, Am J Med, 107, 561, 10.1016/S0002-9343(99)00294-6 Boudou, 2006, A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism, J Endocrinol Invest, 29, 511, 10.1007/BF03344140 Broadus, 1980, The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism, N Engl J Med, 302, 421, 10.1056/NEJM198002213020801 Silverberg, 1989, Skeletal disease in primary hyperparathyroidism, J Bone Miner Res, 4, 283, 10.1002/jbmr.5650040302 Eriksen, 2002, Primary hyperparathyroidism: lessons from bone histomorphometry, J Bone Miner Res, 17, N95 Dempster, 2007, Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism, Bone, 41, 19, 10.1016/j.bone.2007.03.020 Stein, 2011, Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism, Bone, 48, 557, 10.1016/j.bone.2010.10.004 Dauphine, 1975, Back pain and vertebral crush fractures: an unemphasized mode of presentation for primary hyperparathyroidism, Ann Intern Med, 83, 365, 10.7326/0003-4819-83-3-365 Wilson, 1988, Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures, Ann Intern Med, 109, 959, 10.7326/0003-4819-109-12-959 Larsson, 1993, The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years, J Intern Med, 234, 585, 10.1111/j.1365-2796.1993.tb01017.x Kenny, 1995, Fracture incidence in postmenopausal women with primary hyperparathyroidism, Surgery, 118, 109, 10.1016/S0039-6060(05)80017-0 Khosla, 1999, Primary hyperparathyroidism and the risk of fracture: a population-based study, J Bone Miner Res, 14, 1700, 10.1359/jbmr.1999.14.10.1700 Vignali, 2009, Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism, J Clin Endocrinol Metab, 94, 2306, 10.1210/jc.2008-2006 Vestergaard, 2000, Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism, BMJ, 321, 598, 10.1136/bmj.321.7261.598 Khosla, 2002, Fracture risk in primary hyperparathyroidism, J Bone Miner Res, 17, N103 Walker, 2012, Effect of renal function on skeletal health in primary hyperparathyroidism, J Clin Endocrinol Metab, 97, 1501, 10.1210/jc.2011-3072 Patten, 1974, Neuromuscular disease in primary hyperparathyroidism, Ann Intern Med, 80, 182, 10.7326/0003-4819-80-2-182 Turken, 1989, Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism, Am J Med, 87, 553, 10.1016/S0002-9343(89)80613-8 Silverberg, 2013, Asymptomatic primary hyperparathyroidism, J Clin Densitom, 16, 14, 10.1016/j.jocd.2012.11.005 Prager, 2002, Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism, Surgery, 132, 930, 10.1067/msy.2002.128606 Roman, 2005, Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism, Surgery, 138, 1121, 10.1016/j.surg.2005.08.033 Chiang, 2005, A controlled, prospective study of neuropsychological outcomes post parathyroidectomy in primary hyperparathyroid patients, Clin Endocrinol (Oxf), 62, 99, 10.1111/j.1365-2265.2004.02180.x Benge, 2009, Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy, J Int Neuropsychol Soc, 15, 1002, 10.1017/S1355617709990695 Walker, 2009, Neuropsychological features in primary hyperparathyroidism: a prospective study, J Clin Endocrinol Metab, 94, 1951, 10.1210/jc.2008-2574 Roman, 2011, The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism, Ann Surg, 253, 131, 10.1097/SLA.0b013e3181f66720 Perrier, 2009, Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism, Surgery, 146, 1116, 10.1016/j.surg.2009.09.034 Brown, 1987, Neurobehavioral symptoms in mild primary hyperparathyroidism: related to hypercalcemia but not improved by parathyroidectomy, Henry Ford Hosp Med J, 35, 211 Solomon, 1994, Psychologic symptoms before and after parathyroid surgery, Am J Med, 96, 101, 10.1016/0002-9343(94)90128-7 Espiritu, 2011, Depression in primary hyperparathyroidism: prevalence and benefit of surgery, J Clin Endocrinol Metab, 96, E1737, 10.1210/jc.2011-1486 Pasieka, 2002, Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism, World J Surg, 26, 942, 10.1007/s00268-002-6623-y Sheldon, 2002, Surgical treatment of hyperparathyroidism improves health-related quality of life, Arch Surg, 137, 1022, 10.1001/archsurg.137.9.1022 Quiros, 2003, Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy, Surgery, 134, 675, 10.1016/S0039-6060(03)00316-7 Amstrup, 2011, Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controls, Eur J Endocrinol, 165, 753, 10.1530/EJE-11-0301 Rao, 2004, Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism, J Clin Endocrinol Metab, 89, 5415, 10.1210/jc.2004-0028 Bollerslev, 2007, Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial, J Clin Endocrinol Metab, 92, 1687, 10.1210/jc.2006-1836 Ambrogini, 2007, Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial, J Clin Endocrinol Metab, 92, 3114, 10.1210/jc.2007-0219 Nilsson, 2002, Clinical presentation of primary hyperparathyroidism in Europe—nationwide cohort analysis on mortality from nonmalignant causes, J Bone Miner Res, 17, N68 Ogard, 2004, Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in Denmark, World J Surg, 28, 108, 10.1007/s00268-003-7046-0 Wermers, 1998, Survival after the diagnosis of hyperparathyroidism: a population-based study, Am J Med, 104, 115, 10.1016/S0002-9343(97)00270-2 Bollerslev, 2009, Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism, J Clin Endocrinol Metab, 94, 2255, 10.1210/jc.2008-2742 Rubin, 2005, Arterial stiffness in mild primary hyperparathyroidism, J Clin Endocrinol Metab, 90, 3326, 10.1210/jc.2004-1400 Walker, 2009, Carotid vascular abnormalities in primary hyperparathyroidism, J Clin Endocrinol Metab, 94, 3849, 10.1210/jc.2009-1086 Walker, 2010, Cardiac structure and diastolic function in mild primary hyperparathyroidism, J Clin Endocrinol Metab, 95, 2172, 10.1210/jc.2009-2072 Iwata, 2012, Aortic valve calcification in mild primary hyperparathyroidism, J Clin Endocrinol Metab, 97, 132, 10.1210/jc.2011-2107 Walker, 2012, Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism, Eur J Endocrinol, 167, 277, 10.1530/EJE-12-0124 Khoo, 2009, Acute pancreatitis in primary hyperparathyroidism: a population-based study, J Clin Endocrinol Metab, 94, 2115, 10.1210/jc.2008-1965 Fitzpatrick, 1987, Acute primary hyperparathyroidism, Am J Med, 82, 275, 10.1016/0002-9343(87)90068-4 Cusano, 2013, Normocalcemic primary hyperparathyroidism, J Clin Densitom, 16, 33, 10.1016/j.jocd.2012.12.001 Dowthwaite, 2013, Surgical management of primary hyperparathyroidism, J Clin Densitom, 16, 48, 10.1016/j.jocd.2012.11.006 Udelsman, 2013, Surgery in primary hyperparathyroidism: extensive personal experience, J Clin Densitom, 16, 54, 10.1016/j.jocd.2012.11.007 Rao, 1988, Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism, J Clin Endocrinol Metab, 67, 1294, 10.1210/jcem-67-6-1294 Silverberg, 1999, A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery, N Engl J Med, 341, 1249, 10.1056/NEJM199910213411701 Rubin, 2008, The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years, J Clin Endocrinol Metab, 93, 3462, 10.1210/jc.2007-1215 National Institutes of Health, 1991, Consensus development conference statement on primary hyperparathyroidism, J Bone Miner Res, 6, S9 Bilezikian, 2002, Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century, J Bone Miner Res, 17, N2 Bilezikian, 2009, Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary Statement from the Third International Workshop, J Clin Endocrinol Metab, 94, 335, 10.1210/jc.2008-1763 Silverberg, 1996, Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism, J Clin Endocrinol Metab, 81, 4007, 10.1210/jc.81.11.4007 Silverberg, 2002, Age as a criterion for surgery in primary hyperparathyroidism, Am J Med, 113, 681, 10.1016/S0002-9343(02)01306-2 Locker, 1997, Optimal dietary calcium intake in primary hyperparathyroidism, Am J Med, 102, 543, 10.1016/S0002-9343(97)00053-3 Khan, 2009, Medical management of asymptomatic primary hyperparathyroidism: Proceedings of the Third International Workshop, J Clin Endocrinol Metab, 94, 373, 10.1210/jc.2008-1762 Marcus, 1984, Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism, Ann Intern Med, 100, 633, 10.7326/0003-4819-100-5-633 Grey, 1996, Effect of hormone replacement therapy on BMD in post-menopausal women with primary hyperparathyroidism, Ann Intern Med, 125, 360, 10.7326/0003-4819-125-5-199609010-00002 Rubin, 2003, Raloxifene lowers serum calcium and markers of bone turnover in primary hyperparathyroidism, J Clin Endocrinol Metab, 88, 1174, 10.1210/jc.2002-020667 Kahn, 2004, Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial, J Clin Endocrinol Metab, 89, 3319, 10.1210/jc.2003-030908 Chow, 2003, Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism, J Clin Endocrinol Metab, 88, 581, 10.1210/jc.2002-020890 Peacock, 2005, Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism, J Clin Endocrinol Metab, 90, 135, 10.1210/jc.2004-0842 Peacock, 2009, Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study, J Clin Endocrinol Metab, 94, 4860, 10.1210/jc.2009-1472 Peacock, 2011, Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity, J Clin Endocrinol Metab, 96, E9, 10.1210/jc.2010-1221 Wermers, 1997, The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992, Ann Intern Med, 126, 433, 10.7326/0003-4819-126-6-199703150-00003 Wermers, 2006, Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease, J Bone Miner Res, 21, 171, 10.1359/JBMR.050910